EUVIMEDEUVIMED entdecken
Übersichtsarbeit

INDIVIDUAL ARTICLE: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab

Naiem T Issa, Shawn Kwatra, Ali Shahbaz, Leon Kircik

Journal of Drugs in Dermatology · 2026

DOI: 10.36849/jdd.015471 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Naiem T Issa und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Prurigo, Interleukins, Antibodies, Monoclonal, Humanized.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPrurigoInterleukinsAntibodies, Monoclonal, HumanizedHumansTreatment OutcomeReceptors, InterleukinClinical Trials, Phase III as Topic

Substanzen

InterleukinsAntibodies, Monoclonal, HumanizedIL31 protein, humannemolizumabIL31RA protein, humanReceptors, Interleukin

Zitieren

APA

Issa, N. T., Kwatra, S., Shahbaz, A., & Kircik, L. (2026). INDIVIDUAL ARTICLE: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.015471

Vancouver

Issa NT, Kwatra S, Shahbaz A, Kircik L. INDIVIDUAL ARTICLE: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.015471

BibTeX
@article{Issa2026,
  author = {Issa, Naiem T and Kwatra, Shawn and Shahbaz, Ali and Kircik, Leon},
  title = {INDIVIDUAL ARTICLE: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  doi = {10.36849/jdd.015471}
}
Kostenlos starten →